{"organizations": [], "uuid": "80f42e602d20d7e0fbb170e9379089cd1997b023", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-vertex-pharmaceuticals-ceo-leidens/brief-vertex-pharmaceuticals-ceo-leidens-2017-compensation-was-17-2-mln-idUSFWN1RJ0JP", "country": "US", "domain_rank": 408, "title": "BRIEF-Vertex Pharmaceuticals CEO Leiden's 2017 Compensation Was $17.2 Mln", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-06T23:34:00.000+03:00", "replies_count": 0, "uuid": "80f42e602d20d7e0fbb170e9379089cd1997b023"}, "author": "", "url": "https://www.reuters.com/article/brief-vertex-pharmaceuticals-ceo-leidens/brief-vertex-pharmaceuticals-ceo-leidens-2017-compensation-was-17-2-mln-idUSFWN1RJ0JP", "ord_in_thread": 0, "title": "BRIEF-Vertex Pharmaceuticals CEO Leiden's 2017 Compensation Was $17.2 Mln", "locations": [], "entities": {"persons": [{"name": "jeffrey leiden", "sentiment": "none"}], "locations": [], "organizations": [{"name": "brief-vertex pharmaceuticals ceo leiden", "sentiment": "negative"}, {"name": "leiden", "sentiment": "negative"}, {"name": "brief-vertex pharmaceuticals", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}, {"name": "mln reuters staff", "sentiment": "none"}, {"name": "vertex pharmaceuticals inc", "sentiment": "none"}, {"name": "vertex pharmaceuticals inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 6, 2018 / 8:36 PM / Updated 4 minutes ago BRIEF-Vertex Pharmaceuticals CEO Leiden's 2017 Compensation Was $17.2 Mln Reuters Staff 1 Min Read \nApril 6 (Reuters) - Vertex Pharmaceuticals Inc: \n* VERTEX PHARMACEUTICALS INC - CEO JEFFREY LEIDEN'S 2017 TOTAL COMPENSATION WAS $17.2 MLN VS $17.4 MLN IN 2016 - SEC FILING Source text - bit.ly/2uQs5Cx Further company coverage:", "external_links": [], "published": "2018-04-06T23:34:00.000+03:00", "crawled": "2018-04-06T23:51:51.000+03:00", "highlightTitle": ""}